MEDIUM · 6.5

CVE-2020-27268

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically prox...

Vulnerability Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.

CVSS Score

6.5

MEDIUM

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Attack Vector
ADJACENT_NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
NONE
Availability
NONE

Affected Products

VendorProductVersions
SooilAnydana-A Firmware< 3.0
SooilAnydana-A-
SooilAnydana-I Firmware< 3.0
SooilAnydana-I-
SooilDiabecare Rs Firmware< 3.0
SooilDiabecare Rs-

Related Weaknesses (CWE)

References

FAQ

What is CVE-2020-27268?

CVE-2020-27268 is a vulnerability with a CVSS score of 6.5 (MEDIUM). In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically prox...

How severe is CVE-2020-27268?

CVE-2020-27268 has been rated MEDIUM with a CVSS base score of 6.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2020-27268?

Check the references section above for vendor advisories and patch information. Affected products include: Sooil Anydana-A Firmware, Sooil Anydana-A, Sooil Anydana-I Firmware, Sooil Anydana-I, Sooil Diabecare Rs Firmware.